Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Setnik

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of Pain Research|July 18, 2015
A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe painBeatrice Setnik, Carl L Roland, Kenneth W Sommerville, et al.
Journal of Opioid Management|January 6, 2016
Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States cityBeatrice Setnik, Carl L Roland, Veeraindar Goli, et al.
Sleep|October 19, 2019
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexyBeatrice Setnik, Michael McDonnell, Catherine Mills, et al.
Journal of Opioid Management|February 11, 2012
Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care settingJames Brown, Beatrice Setnik, Keung Lee, et al.
Epilepsy & Behavior : E&B|October 5, 2018
Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trialKerri A Schoedel, Isabella Szeto, Beatrice Setnik, et al.
The American Journal of Drug and Alcohol Abuse|May 24, 2016
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid usersMiroslav Backonja, Lynn R Webster, Beatrice Setnik, et al.
Journal of Clinical Pharmacology|August 14, 2018
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled TrialSanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Pain Medicine (Malden, Mass.)|August 24, 2016
Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid UsersBeatrice Setnik, Almasa Bass, Candace Bramson, et al.
Journal of Clinical Pharmacology|May 27, 2015
Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid usersBeatrice Setnik, Candace Bramson, Almasa Bass, et al.
Journal of Opioid Management|December 23, 2014
A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer painSamir Arora, Beatrice Setnik, Drass Michael, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Pain Research|July 18, 2015
A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe painBeatrice Setnik, Carl L Roland, Kenneth W Sommerville, et al.
Journal of Opioid Management|January 6, 2016
Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States cityBeatrice Setnik, Carl L Roland, Veeraindar Goli, et al.
Sleep|October 19, 2019
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexyBeatrice Setnik, Michael McDonnell, Catherine Mills, et al.
Journal of Opioid Management|February 11, 2012
Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care settingJames Brown, Beatrice Setnik, Keung Lee, et al.
Epilepsy & Behavior : E&B|October 5, 2018
Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trialKerri A Schoedel, Isabella Szeto, Beatrice Setnik, et al.
The American Journal of Drug and Alcohol Abuse|May 24, 2016
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid usersMiroslav Backonja, Lynn R Webster, Beatrice Setnik, et al.
Journal of Clinical Pharmacology|August 14, 2018
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled TrialSanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Pain Medicine (Malden, Mass.)|August 24, 2016
Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid UsersBeatrice Setnik, Almasa Bass, Candace Bramson, et al.
Journal of Clinical Pharmacology|May 27, 2015
Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid usersBeatrice Setnik, Candace Bramson, Almasa Bass, et al.
Journal of Opioid Management|December 23, 2014
A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer painSamir Arora, Beatrice Setnik, Drass Michael, et al.
Pageof 5